Acquisition of Avo Photonics, Inc
July 11, 2011
Halma, the leading safety, health and sensor technology group, announces the acquisition of Avo Photonics, Inc (‘Avo’) on 8 July 2011 from Blaine Hobson, Whitecap Partners, other shareholders and employees for an initial cash consideration of $9.0 million (£5.6 million). Avo, based in Pennsylvania, USA, designs and manufactures advanced, miniaturised photonic components and subsystems for [...]
Isogenica Expands Discovery Capacity with Investment in New Automation Facility
July 11, 2011
CAMBRIDGE, England - Isogenica Ltd today announced the opening of a new automation facility at their current location, Chesterford Research Park. Following a substantial refit of additionally acquired space, this new facility will house the high throughput CIS display platform for the discovery of biological therapeutics, diagnostics and reagents using Tecan liquid handling robots and [...]
July 11, 2011
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE: A) today introduced the first commercially available capacitance calibration standard for an atomic force microscope (AFM). The scientific solutions provider issued calibration specifications for capacitance measurements that allow quantitative assessment of material and device properties via its award-winning Scanning Microwave Microscopy Mode. Researchers from Agilent collaborated with [...]
Abnova Introduces High Throughput TR-FRET Assay System (Interactor®) for Drug Discovery Market
July 11, 2011
Neihu, Taiwan - Abnova Corporation and Biotek announced today the collaboration and introduction of a high throughput, protein-protein interaction (PPI) assay system (Interactor®) based on time-resolved fluorescence resonance energy transfer (TR-FRET). While conventional applications of TR-FRET focus primarily on GPCR second messengers and kinases, the emerging field of PPIs as druggable targets for high throughput [...]
QIAGEN Updates Proposal to Acquire Cellestis Limited
July 11, 2011
Venlo, the Netherlands, and Melbourne, Australia - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has amended its original proposal to acquire Cellestis Limited (CST:AU), a publicly traded Australian biotechnology company. Under terms of the amended proposal, the per-share offer price is being increased by 7% to A$3.80 from the original [...]
LaserGen and National Instruments Collaborate to Improve Accuracy of DNA Sequencing
July 11, 2011
HOUSTON - LaserGen Inc. and National Instruments today announced a collaboration to develop a new next-generation sequencing (NGS) system. The system will be initially used to demonstrate accurate sequencing of the E. coli genome in the upcoming months using LaserGen's Lightning Terminators™, a breakthrough sequencing chemistry for reversible terminators, and National Instruments graphical system design [...]
July 11, 2011
CARLSBAD, Calif. – Ion Torrent, a unit of Life Technologies Corporation (NASDAQ: LIFE), today announced that it is shipping its new 100 Mb Ion 316? chip, which has tenfold more throughput than the original Ion 314? chip, and that its 1 Gb Ion 318? chip will be available in the fourth quarter. These three chips [...]
Eurofins MWG Operon Announces the Opening of a New DNA Sequencing Facility in the SF Bay Area
July 11, 2011
Petaluma, CA - Eurofins MWG Operon has opened a new DNA sequencing facility in the San Francisco area. The new facility, located in the city of Petaluma, just north of San Francisco, will provide overnight Sanger DNA sequencing services to the SF Bay Area and next day service to the western United States. “Strong growth [...]
Genedata Announces Membership in Netherlands Toxicogenomics Centre
July 11, 2011
Tokyo, Japan - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced announced it has become a member of the Netherlands Toxicogenomics Centre (NTC). NTC uses toxicogenomics to advance the understanding of toxicological mechanisms and provide more humane alternatives to animal testing in the development of drug [...]
Sequenom Announces Multi-Year Supply Agreement With Illumina
July 11, 2011
SAN DIEGO - Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it has signed a three-year supply agreement with Illumina, Inc., a leading developer and manufacturer of life sciences tools for the large-scale analysis of genetic variation and function. Under the terms of the agreement, Sequenom and its [...]

